molecules of the month

LMB763 (nidufexor)

selective FXR partial agonist

orally efficacious in NASH models

from two 3M compound HTS and LBD

J. Med. Chem., Jan. 15, 2020

Novartis (GNF), San Diego, CA

LMB763 (nidufexor)
1 min read

LMB763 (nidufexor) (Novartis (GNF) oral in vivo selective FXR partial agonist)

request a trial

Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.

Request a trial to access insights powering the pros in our industry.

already a member? log in: